 MINNEAPOLIS--BUSINESS WIRE--DiaMedica Therapeutics Inc. Nasdaq: DMAC, a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today announced that the Company will be presenting two abstracts at the National Kidney Foundation NKF 2021 Spring Clinical Meetings SCM21 being held virtually from April 6 10, 2021. For information about the virtual event, visit: The DiaMedica abs 